How to take advantage of easily available biomarkers in patients with IgA nephropathy: IgA and C3 in serum and kidney biopsies

Pediatr Nephrol. 2023 May;38(5):1439-1448. doi: 10.1007/s00467-022-05644-9. Epub 2022 Aug 2.

Abstract

IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide. It is diagnosed based on clinical and histological features including predominant IgA deposits in kidney biopsy. The multi-hit theory, based on the production of GDIgA1 and anti-GDIgA1 antibodies, and complement activation via alternative and lectin pathways and also a genetic tendency are crucial in the pathogenesis of IgAN. The aim of the present review is to summarize the utility of routine diagnostic tests in IgA nephropathy, such as IgA and C3 in serum and kidney biopsy specimens, for predicting the disease progression. The paper also contains data on new markers used in the diagnosis and prognosis of IgA nephropathy.

Keywords: C3; C3 deposits; IgA; IgA deposits; IgA nephropathy.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biopsy
  • Glomerulonephritis, IGA* / pathology
  • Humans
  • Immunoglobulin A
  • Kidney / pathology

Substances

  • Immunoglobulin A
  • Biomarkers